Clinomics Inc. (KOSDAQ:352770)
South Korea
· Delayed Price · Currency is KRW 625.00
+144.00 (29.94%)
Feb 20, 2025, 9:00 AM KST
Clinomics Market Cap
Clinomics has a market cap or net worth of 22.45 billion as of February 21, 2025. Its market cap has decreased by -69.27% in one year.
Market Cap
22.45B
Enterprise Value
51.34B
Revenue
8.25B
Ranking
n/a
PE Ratio
n/a
Stock Price
625.00
Market Cap Chart
Since December 4, 2020, Clinomics's market cap has decreased from 250.90B to 22.45B, a decrease of -91.05%. That is a compound annual growth rate of -43.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 22.45B | 12.31% |
| Dec 30, 2024 | 19.99B | -75.62% |
| Dec 28, 2023 | 82.01B | -6.89% |
| Dec 29, 2022 | 88.08B | -48.30% |
| Dec 30, 2021 | 170.35B | -24.47% |
| Dec 30, 2020 | 225.54B | -10.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 384.51T |
| SK hynix | 144.35T |
| LG Energy Solution | 88.57T |
| Samsung Biologics | 82.35T |
| Hyundai Motor Company | 45.50T |
| Celltrion | 37.80T |
| Kia Corporation | 36.86T |
| NAVER | 34.26T |